China Universal Asset Management Co. Ltd. Buys 1,183 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

China Universal Asset Management Co. Ltd. increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,026 shares of the medical equipment provider's stock after purchasing an additional 1,183 shares during the period. China Universal Asset Management Co. Ltd.'s holdings in Intuitive Surgical were worth $5,461,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Interchange Capital Partners LLC grew its position in Intuitive Surgical by 13.7% in the 1st quarter. Interchange Capital Partners LLC now owns 1,078 shares of the medical equipment provider's stock valued at $534,000 after buying an additional 130 shares during the last quarter. Crossmark Global Holdings Inc. lifted its holdings in shares of Intuitive Surgical by 14.1% in the 1st quarter. Crossmark Global Holdings Inc. now owns 23,523 shares of the medical equipment provider's stock valued at $11,650,000 after buying an additional 2,905 shares during the period. J Hagan Capital Inc. purchased a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $313,000. Callan Capital LLC grew its holdings in Intuitive Surgical by 6.9% during the first quarter. Callan Capital LLC now owns 1,101 shares of the medical equipment provider's stock worth $545,000 after acquiring an additional 71 shares during the period. Finally, TD Private Client Wealth LLC raised its position in Intuitive Surgical by 71.3% in the first quarter. TD Private Client Wealth LLC now owns 6,832 shares of the medical equipment provider's stock worth $3,384,000 after acquiring an additional 2,844 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Trading Down 1.4%

NASDAQ ISRG traded down $7.41 during trading on Tuesday, reaching $527.30. The company's stock had a trading volume of 1,608,552 shares, compared to its average volume of 1,672,097. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00. The business has a 50-day moving average price of $537.53 and a 200-day moving average price of $536.99. The stock has a market capitalization of $188.99 billion, a PE ratio of 77.32, a PEG ratio of 5.67 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the company earned $1.50 EPS. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of recent analyst reports. Robert W. Baird lowered their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Barclays decreased their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday. Finally, BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $592.59.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president owned 2,245 shares in the company, valued at $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,998 shares of company stock valued at $2,611,577. Company insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.